Castle Biosciences Statistics
NASDAQ: CSTLHealth CareMedical SpecialitiesUSD
33.71+0.71 (+2.15%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Castle Biosciences by the numbers
Castle Biosciences has a market capitalization of $1.03 billion based on 30.55M shares outstanding. With trailing EPS of $-0.64, Castle Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.4% above its 50-day average and 16.2% above its 200-day average.
Average daily trading volume is 401.17K shares, or about $13.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CSTL valuation vs. peer median
| Metric | CSTL | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.03B | $1.41B | -27% |
| Avg. volume | 401.17K | 630.01K | -36% |
Peer median across 8 companies: TRUP, YDES, FRNM, BDSX, ALHC, XGN, FTRE, CLOV.
Valuation
- Market cap
- $1.03B
- EPS (TTM)
- $-0.64
- Shares outstanding
- 30.55M
Price and trading
- Previous close
- 33.00
- Open
- 32.54
- Day range
- 32.35 – 33.76
- 52-week range
- 17.72 – 44.28
- 52-week change
- +42.90%
- Beta
- —
- Volume
- 373.80K
- Average volume
- 401.17K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 1.03B
- Forward Pe
- -35.90
- Eps
- -0.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 44.28
- Week52 Low
- 17.72
- Avg Volume
- 401.17K
- Shares Outstanding
- 30.55M
- Ma50
- 32.92
- Ma200
- 29.01
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -23.87%
- Pct From52w Low
- 90.22%